Bremer Trust National Association Sells 561 Shares of Stryker Corporation (SYK)
Bremer Trust National Association trimmed its stake in shares of Stryker Corporation (NYSE:SYK) by 4.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,530 shares of the medical technology company’s stock after selling 561 shares during the quarter. Bremer Trust National Association’s holdings in Stryker were worth $1,786,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the business. Acrospire Investment Management LLC purchased a new position in shares of Stryker during the 2nd quarter worth approximately $111,000. Sawyer & Company Inc purchased a new position in shares of Stryker during the 4th quarter worth approximately $125,000. Sit Investment Associates Inc. raised its stake in shares of Stryker by 114.3% during the 4th quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock worth $128,000 after buying an additional 440 shares in the last quarter. Motco raised its stake in shares of Stryker by 50.7% during the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares in the last quarter. Finally, Oak Point Wealth Management purchased a new position in shares of Stryker during the 4th quarter worth approximately $145,000. 74.90% of the stock is owned by institutional investors.
Stryker Corporation (NYSE:SYK) traded down $0.37 during midday trading on Friday, reaching $158.23. The company had a trading volume of 1,138,974 shares, compared to its average volume of 1,207,278. Stryker Corporation has a 12-month low of $119.17 and a 12-month high of $164.20. The stock has a market cap of $59,220.00, a P/E ratio of 33.74, a P/E/G ratio of 2.30 and a beta of 0.78. The company has a quick ratio of 1.61, a current ratio of 2.37 and a debt-to-equity ratio of 0.63.
Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.50 by $0.02. Stryker had a return on equity of 24.11% and a net margin of 14.67%. The firm had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. During the same period last year, the business posted $1.39 EPS. Stryker’s quarterly revenue was up 6.1% on a year-over-year basis. equities research analysts anticipate that Stryker Corporation will post 6.47 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a $0.47 dividend. This is an increase from Stryker’s previous quarterly dividend of $0.43. This represents a $1.88 annualized dividend and a yield of 1.19%. The ex-dividend date is Thursday, December 28th. Stryker’s dividend payout ratio (DPR) is presently 40.09%.
A number of equities analysts have recently issued reports on SYK shares. Wells Fargo & Co increased their target price on Stryker from $160.00 to $166.00 in a research note on Friday, October 27th. Canaccord Genuity increased their target price on Stryker from $155.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday, October 27th. Stifel Nicolaus increased their target price on Stryker from $158.00 to $168.00 and gave the stock a “buy” rating in a research note on Friday, October 27th. Cowen set a $160.00 target price on Stryker and gave the stock a “buy” rating in a research note on Friday, October 6th. Finally, Royal Bank of Canada reissued a “buy” rating and set a $155.00 target price on shares of Stryker in a research note on Monday, October 2nd. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. Stryker currently has a consensus rating of “Hold” and an average price target of $156.60.
In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the transaction, the insider now owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 7.40% of the company’s stock.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.